Webinar: EMA´s Q & A regarding PDE-values

Thursday, 17 October 2019 14.00 - 15.30 h

Course No. 17653



Robert G. Schwarz

Robert G. Schwarz



Preventing cross contamination is an essential GMP-requirement and has already been mentioned in the EU GMP Guideline since its first publication in 1989. However, in the last years this requirement has become more and more relevant. There is a stronger focus on cross contamination since the EMA has published their „shared and dedicated facility guideline“ regarding the use of multi-purpose equipment. In this guideline, health-based exposure limits (HBEL) and permitted daily exposure-values (PDE) are implemented as state of the art values. Consequently, the chapter 5 of the EU GMP Guideline and the Annex 15 have been revised in the same direction. A Question and Answers (Q&A) draft document and now the final version should interpret EMA´s „shared and dedicated facility guideline“. De facto, these two Q&A´s have led to some confusion in the pharmaceutical industry.

Target Group

We address staff from the pharmaceutical industry and API manufacturers who are interested in the topics cross contamination and cleaning validation, e.g. head of production, validation managers, QA-personnel etc.

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.


  • What is a Q&A document?
  • The PDE concept – how was it developed?
  • Why the use of HBEL/PDE values?
  • How to get HBEL/PDE values?
  • EMA´s Q &A document for the interpretation of EMA´s 
  • “Shared and Dedicated Facilities” guideline
  • Comparison of the Q &A draft (2016) and the final version (2018) – What changes?
  • Influence of the Q & A document on cleaning validation

ECA-Member*: € 199,-
Non ECA Member*: € 249,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

Further dates on-site
Further dates on-site
Not available
Further dates online
Further dates online
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023


“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024


“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024



“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023